Dr. Sharvil Patel

Vice President, IPA and Managing Director, Zydus Lifesciences Ltd.

Dr. Sharvil Patel is the Managing Director of Zydus Lifesciences Ltd., a global innovation-driven lifesciences company which has a legacy of over 70 years in the field of healthcare. Zydus Lifesciences researches, develops, manufactures and markets wide ranging therapeutics, biologicals and vaccines. Besides this, the group is into high-end diagnostics to detect cancers. Dr. Sharvil Patel also officiates as the Chairman on the Board of Zydus Wellness Ltd., which is creating several novel experiences for the health-conscious consumers and has a basket of niche products and iconic brands. With a specialisation in Chemical and Pharmaceutical Sciences from the University of Sunderland, U.K., and a doctorate also from the same university for his research work in Breast Cancer at Johns Hopkins, Bayview Medical Centre, USA, Dr. Sharvil combines both pharma and research expertise.

Dr. Sharvil Patel’s leadership has inspired the organization to explore an expansive canvas of thoughts and ideas which are patient-centric, innovative and futuristic. With a turnover of over Rs. 17000 crores ($2.15 bn), Zydus today has a global presence in over 55 countries worldwide. In the US, the group has been contributing to health and well-being since the last 21 years. The group’s subsidiary, Zydus Pharmaceuticals USA Inc., is based at Pennington, New Jersey, USA. Zydus’ operations in the US are focused on affordable generics, specialty drugs for rare and orphan diseases and the animal health spectrum. The US business contributes to nearly 45% of the group’s revenues.

As an innovation driven organization, Zydus has been bringing in several novel NCEs, novel biologicals, biosimilars and vaccines to the market including the world’s first plasmid DNA vaccine ZyCoV-D to fight Covid-19. The group offers path-breaking discoveries for diseases such as Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steato Hepatitis (NASH), Cancer, Chronic Kidney Disease, amongst others.

With a network of 35 manufacturing plants which includes 9 USFDA inspected facilities and 7 research and development centres, the group is powered by 25000 people worldwide. Dr. Sharvil Patel is also on the Board of Zydus Foundation which spearheads programmes related to healthcare, education, community development through livelihood programme and supporting grassroots innovation.

Zydus Foundation supports the Zydus Medical College and Hospital which offers free of cost treatment to villagers in Dahod, a remote tribal village in Western Gujarat. At the 1000 bed hospital, all treatments and services are free of cost. More than 450,000 OPD patients avail treatment and more than 88000 surgeries are also conducted each year at the hospital.

Dr. Sharvil Patel has been conferred the ET Pharmaleader of the year at the ET Healthworld India Pharma Awards 2022. He has also been conferred the ‘The Economic Times Most Promising Business Leaders of Asia 2020-21’ Award,’ GenNext Entrepreneur of the Forbes India Leadership Awards (FILA) 2020-21’ by the Forbes India and ‘Young Turks Award’ by India Pharma Awards 2021. He received the ‘40 Under 40 Most Influential Asians’ Award by the Asian Business & Social Forum 2018 (ABSF) and the Young Business Leader ’40 under Forty’ Award by ET Now in 2017.